Navigation Links
EPA hosts decontamination research and development conference
Date:4/13/2010

(Durham, NC April 12, 2010) -- The U.S. Environmental Protection Agency's National Homeland Security Research Center will hold its 2010 Decontamination Research and Development Conference on April 13-15, 2010 at the Hilton Raleigh-Durham Airport Hotel in North Carolina.

This year's conference will focus on the decontamination of indoor and outdoor areas and of materials contaminated with biological, chemical, and radiological agents. EPA Office of Research and Development Assistant Administrator, Dr. Paul Anastas, will open the conference with remarks about protecting human health and the environment through scientific innovation. The Honorable David Price, Congressman for the Fourth District of North Carolina, will deliver the keynote address.

WHO: U.S. Representative David Price, Fourth District of North Carolina delivering keynote address; Dr. Paul Anastas, Assistant Administrator for Office of Research & Development, U.S. EPA

WHAT: 2010 U.S. EPA Decontamination Research and Development Conference

WHEN: The conference will be held April 13-15, 2010.

Remarks by Assistant Administrator Dr. Paul Anastas, Tuesday, April 13, 2010, 8:30 a.m.
Keynote address by Representative David Price, Tuesday, April 13, 2010, 9:00 a.m.

WHERE: Hilton Raleigh-Durham Airport Hotel

4810 Page Creek Lane, Durham, North Carolina


'/>"/>

Contact: Dawn Harris-Young
harris-young.dawn@epa.gov
404-562-8421
U.S. Environmental Protection Agency
Source:Eurekalert

Page: 1

Related biology news :

1. UD hosts conference on knowledge-based partnerships Nov. 2
2. NIH hosts event to launch Council of Science Editors global theme issue
3. Brown hosts regional bioengineering conference
4. Rockefeller University hosts 2-day evolution symposium, May 1-2, 2008
5. UTSA hosts North American Energy Summit May 1-2
6. Monarch butterflies help explain why parasites harm hosts
7. Syracuse University scientists discover how some bacteria may steal iron from their human hosts
8. Smithsonian hosts tropical extinction debate in Panama
9. AACR hosts Molecular Diagnostics in Cancer Therapeutic Development Meeting
10. AACR hosts Frontiers in Cancer Prevention Research meeting
11. The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: